TrialRespiratory research2018

Elevated serum soluble programmed cell death ligand 1 concentration as a potential marker for poor prognosis in small cell lung cancer patients with chemotherapy.

Jianjun Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.